Design of human ACE2 mimic miniprotein binders that interact with RBD of SARS-CoV-2 variants of concerns

References

• Alford, R. F., Leaver-Fay, A., Jeliazkov, J. R., O'Meara, M. J., DiMaio, F. P., Park, H., Shapovalov, M. V., Renfrew, P. D., Mulligan, V. K., Kappel, K., Labonte, J. W., Pacella, M. S., Bonneau, R., Bradley, P., Dunbrack, R. L., Das, R., Baker, D., Kuhlman, B., Kortemme, T., & Gray, J. J. (2017). The rosetta all-atom energy function for macromolecular modeling and design. Journal of Chemical Theory and Computation, 13(6), 3031–3048. https://doi.org/10.1021/acs.jctc.7b00125
   PubMed Web of Science ®Google Scholar
• Andrews, N., Stowe, J., Kirsebom, F., Toffa, S., Rickeard, T., Gallagher, E., Gower, C., Kall, M., Groves, N., O'Connell, A.-M., Simons, D., Blomquist, P. B., Zaidi, A., Nash, S., Iwani Binti Abdul Aziz, N., Thelwall, S., Dabrera, G., Myers, R., Amirthalingam, G., … Lopez Bernal, J. (2022). Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant. The New England Journal of Medicine, 386(16), 1532–1546. https://doi.org/10.1056/NEJMoa2119451
   PubMed Web of Science ®Google Scholar
• Barton, M. I., MacGowan, S. A., Kutuzov, M. A., Dushek, O., Barton, G. J., & van der Merwe, P. A. (2021). Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. eLife, 10, e70658. https://doi.org/10.7554/eLife.70658
   PubMed Web of Science ®Google Scholar
• Bartoschik, T., Galinec, S., Kleusch, C., Walkiewicz, K., Breitsprecher, D., Weigert, S., Muller, Y. A., You, C., Piehler, J., Vercruysse, T., Daelemans, D., & Tschammer, N. (2018). Near-native, site-specific and purification-free protein labeling for quantitative protein interaction analysis by MicroScale Thermophoresis. Scientific Reports, 8(1), 4977. https://doi.org/10.1038/s41598-018-23154-3
   PubMedGoogle Scholar
• Bonneau, R., Tsai, J., Ruczinski, I., Chivian, D., Rohl, C., Strauss, C. E., & Baker, D. (2001). Rosetta in CASP4: Progress in ab initio protein structure prediction. Proteins, 5, 119–126. https://doi.org/10.1002/prot.1170
   Google Scholar
• Cao, L., Goreshnik, I., Coventry, B., Case, J. B., Miller, L., Kozodoy, L., Chen, R. E., Carter, L., Walls, A. C., Park, Y. J., Strauch, E. M., Stewart, L., Diamond, M. S., Veesler, D., & Baker, D. (2020). De novo design of picomolar SARS-CoV-2 miniprotein inhibitors. Science (New York, N.Y.), 370(6515), 426–431. https://doi.org/10.1126/science.abd9909
   PubMed Web of Science ®Google Scholar
• Case, J. B., Chen, R. E., Cao, L., Ying, B., Winkler, E. S., Johnson, M., Goreshnik, I., Pham, M. N., Shrihari, S., Kafai, N. M., Bailey, A. L., Xie, X., Shi, P. Y., Ravichandran, R., Carter, L., Stewart, L., Baker, D., & Diamond, M. S. (2021). Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease. Cell Host & Microbe, 29(7), 1151–1161.e5. https://doi.org/10.1016/j.chom.2021.06.008
   PubMed Web of Science ®Google Scholar
• Fleishman, S. J., Leaver-Fay, A., Corn, J. E., Strauch, E.-M., Khare, S. D., Koga, N., Ashworth, J., Murphy, P., Richter, F., Lemmon, G., Meiler, J., & Baker, D. (2011). RosettaScripts: A scripting language interface to the Rosetta macromolecular modeling suite. PLoS One, 6(6), e20161. https://doi.org/10.1371/journal.pone.0020161
   PubMed Web of Science ®Google Scholar
• Gainza, P., Wehrle, S., Van Hall-Beauvais, A., Marchand, A., Scheck, A., Harteveld, Z., Buckley, S., Ni, D., Tan, S., Sverrisson, F., Goverde, C., Turelli, P., Raclot, C., Teslenko, A., Pacesa, M., Rosset, S., Georgeon, S., Marsden, J., Petruzzella, A., … Correia, B. E. (2023). De novo design of protein interactions with learned surface fingerprints. Nature, 617(7959), 176–184. https://doi.org/10.1038/s41586-023-05993-x
   PubMed Web of Science ®Google Scholar
• Gaur, N. K., Goyal, V. D., Kulkarni, K., & Makde, R. D. (2021). Machine learning classifiers aid virtual screening for efficient design of mini-protein therapeutics. Bioorganic & Medicinal Chemistry Letters, 38, 127852. https://doi.org/10.1016/j.bmcl.2021.127852
   PubMed Web of Science ®Google Scholar
• Glasgow, A., Glasgow, J., Limonta, D., Solomon, P., Lui, I., Zhang, Y., Nix, M. A., Rettko, N. J., Zha, S., Yamin, R., Kao, K., Rosenberg, O. S., Ravetch, J. V., Wiita, A. P., Leung, K. K., Lim, S. A., Zhou, X. X., Hobman, T. C., Kortemme, T., & Wells, J. A. (2020). Engineered ACE2 receptor traps potently neutralize SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America, 117(45), 28046–28055. https://doi.org/10.1073/pnas.2016093117
   PubMed Web of Science ®Google Scholar
• Gray, J. J., Moughon, S., Wang, C., Schueler-Furman, O., Kuhlman, B., Rohl, C. A., & Baker, D. (2003). Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations. Journal of Molecular Biology, 331(1), 281–299. https://doi.org/10.1016/s0022-2836(03)00670-3
   PubMed Web of Science ®Google Scholar
• He, Y., Qi, J., Xiao, L., Shen, L., Yu, W., & Hu, T. (2021). Purification and characterization of the receptor-binding domain of SARS-CoV-2 spike protein from Escherichia coli. Engineering in Life Sciences, 21(6), 453–460. https://doi.org/10.1002/elsc.202000106
   PubMed Web of Science ®Google Scholar
• Hunt, A. C., Case, J. B., Park, Y. J., Cao, L., Wu, K., Walls, A. C., Liu, Z., Bowen, J. E., Yeh, H. W., Saini, S., Helms, L., Zhao, Y. T., Hsiang, T.-Y., Starr, T. N., Goreshnik, I., Kozodoy, L., Carter, L., Ravichandran, R., Green, L. B., … Baker, D. (2022). Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice. Science Translational Medicine, 14(646), eabn1252. https://doi.org/10.1126/scitranslmed.abn1252
   PubMed Web of Science ®Google Scholar
• Jeong, B. S., Cha, J. S., Hwang, I., Kim, U., Adolf-Bryfogle, J., Coventry, B., Cho, H. S., Kim, K. D., & Oh, B. H. (2022). Computational design of a neutralizing antibody with picomolar binding affinity for all concerning SARS-CoV-2 variants. mAbs, 14(1), 2021601. https://doi.org/10.1080/19420862.2021.2021601
   PubMed Web of Science ®Google Scholar
• Karoyan, P., Vieillard, V., Gómez-Morales, L., Odile, E., Guihot, A., Luyt, C. E., Denis, A., Grondin, P., & Lequin, O. (2021). Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection. Communications Biology, 4(1), 197. https://doi.org/10.1038/s42003-021-01736-8
   PubMed Web of Science ®Google Scholar
• Kohnke, B., Kutzner, C., & Grubmüller, H. (2020). A GPU-accelerated fast multipole method for GROMACS: Performance and accuracy. Journal of Chemical Theory and Computation, 16(11), 6938–6949. https://doi.org/10.1021/acs.jctc.0c00744
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., & Lynn, A. (2014). g_mmpbsa–a GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Lopez Bernal, J., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., Dabrera, G., Myers, R., Campbell, C. N. J., Amirthalingam, G., Edmunds, M., Zambon, M., Brown, K. E., Hopkins, S., Chand, M., & Ramsay, M. (2021). Effectiveness of covid-19 vaccines against the B.1.617.2 (delta) variant. The New England Journal of Medicine, 385(7), 585–594. https://doi.org/10.1056/NEJMoa2108891
   PubMed Web of Science ®Google Scholar
• Micsonai, A., Wien, F., Bulyáki, É., Kun, J., Moussong, É., Lee, Y.-H., Goto, Y., Réfrégiers, M., & Kardos, J. (2018). BeStSel: A web server for accurate protein secondary structure prediction and fold recognition from the circular dichroism spectra. Nucleic Acids Research, 46(W1), W315–W322. https://doi.org/10.1093/nar/gky497
   PubMed Web of Science ®Google Scholar
• Pinto, D., Sauer, M. M., Czudnochowski, N., Low, J. S., Tortorici, M. A., Housley, M. P., Noack, J., Walls, A. C., Bowen, J. E., Guarino, B., Rosen, L. E., di Iulio, J., Jerak, J., Kaiser, H., Islam, S., Jaconi, S., Sprugasci, N., Culap, K., Abdelnabi, R., … Veesler, D. (2021). Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science (New York, NY), 373(6559), 1109–1116. https://doi.org/10.1126/science.abj3321
   Google Scholar
• Sapay, N., & Tieleman, D. P. (2011). Combination of the CHARMM27 force field with united-atom lipid force fields. Journal of Computational Chemistry, 32(7), 1400–1410. https://doi.org/10.1002/jcc.21726
   PubMed Web of Science ®Google Scholar
• Sun, X., Yi, C., Zhu, Y., Ding, L., Xia, S., Chen, X., Liu, M., Gu, C., Lu, X., Fu, Y., Chen, S., Zhang, T., Zhang, Y., Yang, Z., Ma, L., Gu, W., Hu, G., Du, S., Yan, R., … Sun, B. (2022). Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2. Nature Microbiology, 7(7), 1063–1074. https://doi.org/10.1038/s41564-022-01155-3
   PubMed Web of Science ®Google Scholar
• Tan, S., Kern, R. C., & Selleck, W. (2005). The pST44 polycistronic expression system for producing protein complexes in Escherichia coli. Protein Expression and Purification, 40(2), 385–395. https://doi.org/10.1016/j.pep.2004.12.002
   PubMed Web of Science ®Google Scholar
• Wang, Y., Liu, C., Zhang, C., Wang, Y., Hong, Q., Xu, S., Li, Z., Yang, Y., Huang, Z., & Cong, Y. (2022). Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies. Nature Communications, 13(1), 871. https://doi.org/10.1038/s41467-022-28528-w
   PubMed Web of Science ®Google Scholar
• Webb, B., & Sali, A. (2016). Comparative protein structure modeling using MODELLER. Current Protocols in Bioinformatics, 54, 5.6.1–5.6.37. https://doi.org/10.1002/cpbi.3
   PubMedGoogle Scholar
• World Health Organization. (2023). Tracking SARS-CoV-2 variants. www.who.int. Published 2021. Accessed August 15, https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/
   Google Scholar
• Xie, J., Ding, C., He, J., Zhang, Y., Ni, S., Zhang, X., Chen, Q., Wang, J., Huang, L., He, H., Li, W., Ma, H., Jin, T., Zhang, S., & Gao, Y. (2021). Novel monoclonal antibodies and recombined antibodies against variant SARS-CoV-2. Frontiers in Immunology, 12, 715464. https://doi.org/10.3389/fimmu.2021.715464
   PubMed Web of Science ®Google Scholar
• Zhao, F., Keating, C., Ozorowski, G., Shaabani, N., Francino-Urdaniz, I. M., Barman, S., Limbo, O., Burns, A., Zhou, P., Ricciardi, M. J., Woehl, J., Tran, Q., Turner, H. L., Peng, L., Huang, D., Nemazee, D., Andrabi, R., Sok, D., Teijaro, J. R., … Jardine, J. G. (2022). Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways. iScience, 25(9), 104914. https://doi.org/10.1016/j.isci.2022.104914
   PubMed Web of Science ®Google Scholar